Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CNO Financial (CNO) Cash & Equivalents (2016 - 2025)

CNO Financial (CNO) has 17 years of Cash & Equivalents data on record, last reported at $956.1 million in Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 168.72% to $956.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $956.1 million, a 168.72% increase, with the full-year FY2025 number at $956.1 million, up 168.72% from a year prior.
  • Cash & Equivalents reached $956.1 million in Q4 2025 per CNO's latest filing, up from $355.8 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for CNO hit a ceiling of $1.2 billion in Q3 2024 and a floor of $196.2 million in Q4 2021.
  • A 5-year average of $612.0 million and a median of $566.3 million in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 79.08% in 2021, then skyrocketed 193.43% in 2022.
  • Tracing CNO's Cash & Equivalents over 5 years: stood at $196.2 million in 2021, then surged by 193.43% to $575.7 million in 2022, then surged by 34.53% to $774.5 million in 2023, then plummeted by 54.06% to $355.8 million in 2024, then surged by 168.72% to $956.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for CNO at $956.1 million in Q4 2025, $355.8 million in Q4 2024, and $1.2 billion in Q3 2024.